NDC 0061-8134 - Orbenin-DC

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0061-8134
Package NDCs from labels
0061-8134-01, 0061-8134-06
Manufacturer
Merck Sharp & Dohme Corp.
Effective date
2024-11-13
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Orbenin-DC™ (cloxacillin benzathine intramammary infusion)Merck Sharp & Dohme Corp.2024-11-13PRESCRIPTION ANIMAL DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0061-8134-01Orbenin-DC12 in 1 CARTONSUSPENSION126
0061-8134-01Orbenin-DC7.5 mL in 1 SYRINGESUSPENSION7.56
0061-8134-06Orbenin-DC144 in 1 PAILSUSPENSION1446
0061-8134-06Orbenin-DC7.5 mL in 1 SYRINGESUSPENSION7.56

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0061-8134ORBENIN-DC (CLOXACILLIN BENZATHINE) SUSPENSION [MERCK SHARP & DOHME CORP.]64 package rows20241115_0fc4b59b-30b4-480f-bad9-460e30209a35.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
cloxacillin benzathineACTIVE INGREDIENTAC79L7PV2GORBENIN-DC (CLOXACILLIN BENZATHINE) SUSPENSION [MERCK SHARP & DOHME CORP.]1
cloxacillinACTIVE MOIETYO6X5QGC2VBORBENIN-DC (CLOXACILLIN BENZATHINE) SUSPENSION [MERCK SHARP & DOHME CORP.]1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.